Related Experiment Video
Updated: Mar 1, 2026

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
CRISPR-Cas Genome Surgery in Ophthalmology
James E DiCarlo1,2, Jesse D Sengillo1,2,3, Sally Justus1,2
1Jonas Children's Vision Care, and Bernard & Shirlee Brown Glaucoma Laboratory, Department of Ophthalmology, Columbia University, New York, NY, USA.
Gene therapy using CRISPR-Cas tools offers new hope for genetic vision diseases. These advanced genome-editing technologies are revolutionizing ophthalmology research and treatment development.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Genetic disorders significantly impair vision and quality of life.
- Gene therapy aims to treat the genomic basis of inherited eye diseases.
- CRISPR-Cas systems are powerful genome-editing tools for disease research and therapy.
Purpose of the Study:
- To review recent applications of CRISPR-Cas technology in ophthalmology.
- To highlight the potential of CRISPR-Cas for studying and treating eye diseases.
- To summarize advancements in CRISPR-Cas delivery and optimization for ocular applications.
Main Methods:
- Review of current literature on CRISPR-Cas applications in visual sciences.
- Analysis of studies involving CRISPR-Cas in model organisms (zebrafish, mammals).
- Examination of CRISPR-Cas use in patient-derived stem cells for ocular disease correction.
Main Results:
- CRISPR-Cas has been successfully used to modify models of eye development and disease.
- Gene correction of pathogenic mutations in ocular stem cells has been demonstrated.
- Advances in CRISPR-Cas delivery systems enhance genome engineering in the eye.
Conclusions:
- CRISPR-Cas technology is a transformative tool in ophthalmology.
- These genome-editing systems hold significant promise for treating genetic vision disorders.
- Ongoing advancements will further expand therapeutic and research applications in eye care.
More Related Videos
10:07Construction of Homozygous Mutants of Migratory Locust Using CRISPR/Cas9 Technology
Published on: March 16, 2022
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR
Homologous Recombination
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...